Get started
Author

Elena Salomoni

Observed names: E Salomoni, E. Salomoni, Salomoni E, Salomoni, Elena
ORCID: 0000-0001-6094-2102
Observed ORCID: 0000-0001-6094-2102
OpenAlex ID: A5070466244
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
2020 · Nicola Squillace, Elena Ricci, et al. · Drug Design Development and Therapy · 39
PDF
Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study
2020 · Carlo Pallotto, Lorenzo Roberto Suardi, et al. · Scandinavian Journal of Infectious Diseases · 37
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study
2021 · Lucia Taramasso, Andrea De Vito, et al. · AIDS Patient Care and STDs · 27
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study
2017 · Cristina Stasi, Elena Salomoni, et al. · European Journal of Pharmacology · 27
PDF
Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
2021 · Carlo Pallotto, Pierluigi Blanc, et al. · Journal of Infection · 26
PDF
Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach
2020 · Lorenzo Roberto Suardi, Carlo Pallotto, et al. · International Journal of Infectious Diseases · 23
Candida glabrata prosthetic hip infection.
2012 · Filippo Bartalesi, Stefania Fallani, et al. · PubMed · 23
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort
2020 · Paolo Bonfanti, Andrea De Vito, et al. · Infection and Drug Resistance · 15
PDF
Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual
2024 · Lucia Taramasso, Nicola Squillace, et al. · Journal of the International AIDS Society · 14
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study
2024 · Nicolò Corti, Barbara Menzaghi, et al. · Viruses · 13
PDF
Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents?
2012 · Filippo Bartalesi, Elena Salomoni, et al. · Scandinavian Journal of Infectious Diseases · 7
EACS Abstract 2025
2025 · Taramasso L, Ricci E, et al. · HIV Medicine · 6
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study
2025 · Nicola Squillace, Elena Delfina Ricci, et al. · BMC Infectious Diseases · 5
PDF
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort
2024 · Giuseppe Vittorio De Socio, Elena Ricci, et al. · AIDS · 5
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort
2021 · Maria Giovanna Quaranta, Luigina Ferrigno, et al. · Digestive and Liver Disease · 4
PDF
High SVR Rates with SMV + SOF in HCV GT1 and GT4 Patients with Cirrhosis or Advanced Fibrosis: A Real Practice Analysis from a Large Regional Database in Tuscany, Italy
2016 · E. Salomoni, E. Gianni, et al. · Journal of Hepatology · 2
Effectiveness of first-generation HCV protease inhibitors
2015 · Laura A. Nicolini, Barbara Menzaghi, et al. · European Journal of Gastroenterology & Hepatology · 2
Very short course of triple therapy including telaprevir for chronic hepatitis C: a possible strategy in selected patients
2013 · Giampaolo Corti, Elena Salomoni, et al. · International Journal of Infectious Diseases · 2
Smoking Cessation in People Living With HIV: Results From Italian STOPSHIV Project Cohort
2026 · Debora Altobelli, Elena Ricci, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
2020 · Squillace N, Ricci E, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort
2019 · D. F. Bavaro, D. Di Carlo, et al. · Scandinavian Journal of Infectious Diseases · 1
Sustained Virological Response in HCV Patients Treated with Daclatasvir+Sofosbuvir, with or without Ribavirin: A Multicenter, Field-Practice Experience
2017 · Rodolfo Sacco, Elena Salomoni, et al. · Gastroenterology · 1
Analytical description of adverse events with long-acting injectable cabotegravir and rilpivirine in people living with HIV: a large multicentre prospective observational cohort study (SCOLTA)
2026 · Gaia Cologgi, Elena Ricci, et al. · HIV Research & Clinical Practice
PDF
Distance from low-density lipoprotein cholesterol targets across cardiovascular risk strata in people living with HIV: A multicentre cohort study
2026 · Giuseppe Vittorio De Socio, Anna Gidari, et al. · International Journal of Infectious Diseases
PDF
SC22 Life after long-acting therapy: what happens when CAB/RPV is discontinued?
2026 · M Giurco, L Taramasso, et al. · Sexually Transmitted Infections
PDF
Works count: 41
Citation count: 281
H-index: 10
I10-index: 10
Year
Topic
Type